The acellular therapy market size has grown rapidly in recent years. It will grow from $8.3 billion in 2025 to $9.69 billion in 2026 at a compound annual growth rate (CAGR) of 16.7%. The growth in the historic period can be attributed to increasing research activity in regenerative medicine, early clinical adoption of acellular matrices, growing demand for immune-safe therapies, expansion of wound care applications, improvements in biomaterial processing techniques.
The acellular therapy market size is expected to see rapid growth in the next few years. It will grow to $18.09 billion in 2030 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to rising demand for personalized regenerative treatments, increasing investments in advanced biomaterials, expansion of clinical indications for acellular therapies, growing focus on scalable regenerative solutions, increasing regulatory support for non-cellular therapies. Major trends in the forecast period include increasing adoption of growth factor-based therapies, rising use of extracellular matrix scaffolds, growing focus on cell-free regenerative solutions, expansion of off-the-shelf regenerative products, enhanced integration of translational research platforms.
Download Your Free Report Sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33006&type=smp&utm_source=dev&utm_medium=Paid&utm_campaign=Jul_PR
Which Key Factors Are Supporting Expansion In The Acellular Therapy Market?
The increasing adoption of regenerative medicine is expected to propel the growth of the acellular therapy market going forward. Regenerative medicine refers to medical approaches that repair, replace, or regenerate human cells, tissues, or organs by harnessing biological processes and therapies to restore normal function. Adoption of regenerative medicine is increasing as biotechnology research activity expands globally, with more developers, deeper pipelines, and broader therapeutic exploration. Acellular therapy (AT) supports this trend by providing bioactive, cell free therapeutic materials, such as extracellular vesicles, secretomes, and other biologically active components, that complement regenerative strategies with enhanced safety and standardized dosing. For instance, in june 2024, according to Centre for Commercialization of Regenerative Medicine (CCRM), a Canada-based regenerative medicine organization, there were 2,848 cell and gene therapy developers worldwide as of april 2024, up 11% from quarter four (Q4) 2023, and 1,751 active regenerative medicine clinical trials globally as of april 2024, reflecting sustained clinical engagement and growth in regenerative research activity. Therefore, the increasing adoption of regenerative medicine is driving the growth of the acellular therapy market.
Which Firms Are Leading Innovation In The Acellular Therapy Market?
Major companies operating in the acellular therapy market are Thermo Fisher Scientific, FUJIFILM Holdings Corp., Lonza Group AG, Smith+Nephew, Charles River Laboratories, Sartorius AG, Integra LifeSciences, AGC Biologics, Organogenesis Holdings Inc., MiMedx Group Inc., Vericel Corporation, Avita Medical, Capricor Therapeutics, RoosterBio Inc., Creative Biolabs, Evox Therapeutics Ltd., ILIAS Biologics, Aruna Biomedical, Stem Cell Medicine Ltd., Aegle Therapeutics Corp, Direct Biologics LLC., BioCardia Inc., BioRestorative Therapies Inc., and EverZom.
What Key Trends Are Expected To Reshape The Acellular Therapy Market Landscape?
Major companies operating in the acellular therapy market are focusing on developing small extracellular vesicle (sEV) therapies to enhance tissue regeneration, reduce inflammation, and modulate immune responses by delivering bioactive vesicles directly to affected tissues without introducing living cells. Small extracellular vesicle (sEV) therapies refer to acellular products derived from cultured cells that carry proteins, ribonucleic acids (RNAs), and signaling molecules, enabling targeted modulation of cellular activity, repair of damaged tissue, and immunomodulation. For instance, in march 2025, evast bio, an US-based biotechnology company, developed small extracellular vesicle (sEV) therapy for knee osteoarthritis, which was designed to address key challenges in inflammatory joint disease. The therapy delivers exosomes to inflamed cartilage, promotes regeneration of cartilage extracellular matrix, reduces inflammatory markers, and improves joint function, making it a pioneering acellular therapy (AT) for musculoskeletal inflammation and a model for future extracellular vesicle (sEV) based treatments.
What Emerging Segments Are Influencing The Acellular Therapy Market?
The acellular therapy market covered in this report is segmented –
1) By Type: Acellular Dermal Matrices; Acellular Amniotic Membranes; Acellular Umbilical Cord Products; Other Types
2) By Disease: Parkinson’s; Alzheimer’s; Chronic Wounds; Sclerosis; Cancer
3) By Scaffold: Fused Deposition Modeling (FDM); Cell Laden Hydrogel; Extracellular Matrix (ECM); Selective Laser Sintering (SLS)
4) By Application: Hepatology; Orthopedic; Cardiology; Neurology; Oncology; Gastroenterology
5) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Research Institutes
Subsegments:
1) By Acellular Dermal Matrices: Human Derived Dermal Matrices; Animal Derived Dermal Matrices; Cross Linked Dermal Matrices; Non Cross Linked Dermal Matrices
2) By Acellular Amniotic Membranes: Cryopreserved Amniotic Membranes; Dehydrated Amniotic Membranes; Lyophilized Amniotic Membranes; Laminated Amniotic Membranes
3) By Acellular Umbilical Cord Products: Wharton Jelly Based Products; Umbilical Cord Patch Products; Umbilical Cord Powder Products; Umbilical Cord Sheet Products
4) By Other Types: Acellular Cartilage Matrices; Acellular Bone Matrices; Acellular Vascular Grafts; Acellular Tendon And Ligament Scaffolds
Explore the Complete Acellular Therapy Market Report:
https://www.thebusinessresearchcompany.com/report/acellular-therapy-market-report?utm_source=FreePR&utm_medium=Paid&utm_campaign=Jul_PR
Which Region Is Expected To Hold The Largest Share Of The Acellular Therapy Market?
North America was the largest region in the acellular therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acellular therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Top comments (0)